Literature DB >> 26961571

Clinical Factors Associated with Dose of Loop Diuretics After Pediatric Cardiac Surgery: Post Hoc Analysis.

Roberta Haiberger1, Isabella Favia1, Stefano Romagnoli2,3, Paola Cogo1, Zaccaria Ricci4.   

Abstract

A post hoc analysis of a randomized controlled trial comparing the clinical effects of furosemide and ethacrynic acid was conducted. Infants undergoing cardiac surgery with cardiopulmonary bypass were included in order to explore which clinical factors are associated with diuretic dose in infants with congenital heart disease. Overall, 67 patients with median (interquartile range) age of 48 (13-139) days were enrolled. Median diuretic dose was 0.34 (0.25-0.4) mg/kg/h at the end of postoperative day (POD) 0 and it significantly decreased (p = 0.04) over the following PODs; during this period, the ratio between urine output and diuretic dose increased significantly (p = 0.04). Age (r -0.26, p = 0.02), weight (r -0.28, p = 0.01), cross-clamp time (r 0.27, p = 0.03), administration of ethacrynic acid (OR 0.01, p = 0.03), and, at the end of POD0, creatinine levels (r 0.3, p = 0.009), renal near-infrared spectroscopy saturation (-0.44, p = 0.008), whole-blood neutrophil gelatinase-associated lipocalin levels (r 0.30, p = 0.01), pH (r -0.26, p = 0.02), urinary volume (r -0.2755, p = 0.03), and fluid balance (r 0.2577, p = 0.0266) showed a significant association with diuretic dose. At multivariable logistic regression cross-clamp time (OR 1.007, p = 0.04), use of ethacrynic acid (OR 0.2, p = 0.01) and blood pH at the end of POD0 (OR 0.0001, p = 0.03) was independently associated with diuretic dose. Early resistance to loop diuretics continuous infusion is evident in post-cardiac surgery infants: Higher doses are administered to patients with lower urinary output. Independently associated variables with diuretic dose in our population appeared to be cross-clamping time, the administration of ethacrynic acid, and blood pH.

Entities:  

Keywords:  Acute kidney injury; Cardiopulmonary bypass; Fluid balance; Loop diuretics; Metabolic alkalosis; Pediatric cardiac surgery

Mesh:

Substances:

Year:  2016        PMID: 26961571     DOI: 10.1007/s00246-016-1367-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  24 in total

1.  Acid-base physiology: comments on 10 contentious assertions.

Authors:  Thomas J Morgan; Balasubramanian Venkatesh; Rinaldo Bellomo
Journal:  Crit Care Resusc       Date:  2015-09       Impact factor: 2.159

2.  Pediatric RIFLE for acute kidney injury diagnosis and prognosis for children undergoing cardiac surgery: a single-center prospective observational study.

Authors:  Zaccaria Ricci; Matteo Di Nardo; Claudia Iacoella; Roberta Netto; Stefano Picca; Paola Cogo
Journal:  Pediatr Cardiol       Date:  2013-02-22       Impact factor: 1.655

3.  Lack of renoprotective effects of dopamine and furosemide during cardiac surgery.

Authors:  Andrea Lassnigg; Eva Donner; Georg Grubhofer; Elisabeth Presterl; Wilfred Druml; Michael Hiesmayr
Journal:  J Am Soc Nephrol       Date:  2000-01       Impact factor: 10.121

4.  Continuous intravenous furosemide in haemodynamically unstable children after cardiac surgery.

Authors:  M M van der Vorst; I Ruys-Dudok van Heel; J E Kist-van Holthe; J den Hartigh; R C Schoemaker; A F Cohen; J Burggraaf
Journal:  Intensive Care Med       Date:  2001-04       Impact factor: 17.440

5.  Acute kidney injury after surgery for congenital heart disease.

Authors:  Scott I Aydin; Howard S Seiden; Andrew D Blaufox; Vincent A Parnell; Tarif Choudhury; Ann Punnoose; James Schneider
Journal:  Ann Thorac Surg       Date:  2012-08-09       Impact factor: 4.330

6.  Efficacy and safety of torasemide in children with heart failure.

Authors:  H Senzaki; M Kamiyama; S Masutani; H Ishido; M Taketazu; T Kobayashi; T Katogi; S Kyo
Journal:  Arch Dis Child       Date:  2008-03-12       Impact factor: 3.791

7.  Pharmacodynamic determinants of furosemide diuretic effect in children.

Authors:  J Prandota
Journal:  Dev Pharmacol Ther       Date:  1986

8.  Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass.

Authors:  Michael G Gaies; James G Gurney; Alberta H Yen; Michelle L Napoli; Robert J Gajarski; Richard G Ohye; John R Charpie; Jennifer C Hirsch
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

9.  Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.

Authors:  D L Vargo; W G Kramer; P K Black; W B Smith; T Serpas; D C Brater
Journal:  Clin Pharmacol Ther       Date:  1995-06       Impact factor: 6.875

10.  Furosemide versus ethacrynic acid in pediatric patients undergoing cardiac surgery: a randomized controlled trial.

Authors:  Zaccaria Ricci; Roberta Haiberger; Chiara Pezzella; Cristiana Garisto; Isabella Favia; Paola Cogo
Journal:  Crit Care       Date:  2015-01-07       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.